Stada Launches Bevacizumab Biosimilar In EU

Avastin Rival Oyavas Introduced In Germany And The Netherlands

 
• By Dave Wallace

Stada has launched its Oyavas version of bevacizumab upon EU approval, initially rolling out the oncology biosimilar in Germany and the Netherlands with other countries to follow.

Germany Netherlands Flag Arrow
Oyavas will initially be rolled out in Germany and the Netherlands • Source: Shutterstock

More from Products

More from Generics Bulletin